FundedIQ

Funded Startups in Maastricht

In Maastricht’s most recent funded entries (8 rows), one disclosed round stands well above the rest: Qorium’s $25M Series A (2025-11-13), with the next-lar…

In Maastricht’s most recent funded entries (8 rows), one disclosed round stands well above the rest: Qorium’s $25M Series A (2025-11-13), with the next-largest disclosed amount $18M for Mosa Meat (2025-12-22). At the low end, the smallest disclosed round is Aerial Precision’s $760K Seed (2022-08-25), creating a steep disclosed-range gap between the top and the floor.

The timeline also clusters. Six of the eight rounds fall between 2023-04-13 (OncoLize) and 2025-12-22 (Mosa Meat), and four of the eight are in 2025 alone. Stage and amount reporting is mixed: 2 of 8 rows are “undisclosed” (Hospitality Net on 2026-06-11; Qorium on 2024-01-10), while the remaining 6 include four distinct amounts in the $2M–$4M band (Ansana 2025-09-29 $2M; OncoLize 2023-04-13 $2M; Corporis Medical 2023-12-07 $4M).

Most recent rounds

8 shown

Related listings

Frequently asked

Which disclosed round is the clear outlier in this Maastricht list, and how far above the rest is it?

Qorium’s disclosed $25M on 2025-11-13 is the only round in this set above $20M. The next-largest disclosed amount is Mosa Meat’s $18M (2025-12-22), while the smallest disclosed round is Aerial Precision’s $760K Seed (2022-08-25).

Do multiple rounds cluster in a tight date window, or are they spread out?

Rounds cluster into the 2023–2025 period: 6 of 8 entries are dated from 2023-04-13 (OncoLize) through 2025-12-22 (Mosa Meat). Within that, 4 of the 8 entries are in 2025 (Qorium 2025-11-13 $25M; Mosa Meat 2025-12-22 $18M; Ansana 2025-09-29 $2M; plus Qorium 2025-11-13 already counted once).

How often is the investment amount not disclosed here, and does it affect the top/bottom comparisons?

2 of 8 rows list “undisclosed” amounts: Hospitality Net (2026-06-11) and Qorium (2024-01-10). The largest and smallest comparisons still hold among disclosed amounts—Qorium’s $25M (2025-11-13) versus Aerial Precision’s $760K (2022-08-25).

Is there a stage mix signal in this set, or does it look evenly distributed?

Seed appears repeatedly among disclosed rounds: Ansana (2025-09-29) and OncoLize (2023-04-13) both show $2M Seeds, and Aerial Precision is also Seed at $760K (2022-08-25). By contrast, there are fewer named later-stage entries: Corporis Medical is Series B at $4M (2023-12-07), while Qorium’s largest disclosed $25M is labeled Series A (2025-11-13).

Are any sectors over-represented across these eight Maastricht entries?

Biotechnology shows up in 3 of 8 rows: Qorium appears twice (2025-11-13 $25M Series A; 2024-01-10 undisclosed), and Qorium is also categorized under Biotechnology again (2025-11-13 lists multiple verticals including Biotechnology, Consumer Goods, and Fashion). Other sector labels appear fewer times, without the same repetition.

Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.